By Kelly Davio Antibodies that deplete B cells, including rituximab, have demonstrated efficacy in the treatment of neurological conditions such as progressive multiple sclerosis (MS) and neuromyelitis optica spectrum…
Int J Neurosci. 2016 Apr 1:1-10. [Epub ahead of print] Lin J1, Li X1, Xia J1. Neuromyelitis optica spectrum disorder (NMOSD) has been identified as…